BioPharma Dive February 13, 2023
Sponsored content By By Qiagen

Introducing a new way to improve bioinformatics efficiency in high-throughput NGS settings

It’s exciting that advancements in high-throughput sequencing techniques and analysis enable us to generate whole genome (WGS) and whole exome (WES) data in bulk for many species, including humans. With new machines and chemistries, the cost of sequencing has decreased significantly. However, the total cost of ownership associated with bioinformatic analysis of the resulting files remains a bottleneck.1

Whether you run a genome center, testing facility, core lab or provide sequencing services, you’ve got to deliver variant call files (VCFs) at an unbeatable price and with consistent quality and turnaround time, even at peak demand. Your customers, as well as your business, depend on it. Many high-speed NGS...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article